Menstrual Status, Anesthetic Consumption, and PONV
Impact of Menstrual Phases and Menopause on Intraoperative Anesthetic Consumption and Postoperative Nausea and Vomiting: A Prospective Observational Study
1 other identifier
observational
120
1 country
1
Brief Summary
This prospective observational cohort study aims to evaluate the association between menstrual phase (determined by postoperative serum progesterone levels), intraoperative anesthetic consumption, and the incidence and severity of postoperative nausea and vomiting (PONV) in female patients undergoing cholecystectomy. Intraoperative anesthetic requirements will be recorded, and postoperative nausea and vomiting will be assessed using standardized scoring systems.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 28, 2026
CompletedFirst Posted
Study publicly available on registry
March 6, 2026
CompletedStudy Start
First participant enrolled
March 7, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 27, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2026
CompletedApril 30, 2026
April 1, 2026
3 months
February 28, 2026
April 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intraoperative Anesthetic Agent Consumption
Total amount of anesthetic agents administered during surgery, recorded quantitatively (e.g., mg of intravenous agents and/or minimum alveolar concentration-hours of volatile anesthetics).
From induction of anesthesia to the end of surgery
Secondary Outcomes (2)
Perioperative Hemodynamic Changes
From induction of anesthesia until the end of surgery
Postoperative Vomiting
Within 24 hours after surgery
Study Arms (3)
Follicular Phase Group
Female patients undergoing cholecystectomy under general anesthesia who are classified as being in the follicular phase of the menstrual cycle based on postoperative serum progesterone levels. No experimental intervention will be applied. Intraoperative anesthetic consumption and postoperative nausea and vomiting will be recorded as part of routine perioperative management.
Luteal Phase Group
Female patients undergoing cholecystectomy under general anesthesia who are classified as being in the luteal phase of the menstrual cycle according to postoperative serum progesterone levels. No intervention beyond standard clinical care will be performed. Anesthetic drug consumption and postoperative nausea and vomiting outcomes will be documented.
Postmenopausal Group
Female patients undergoing cholecystectomy under general anesthesia who are postmenopausal. These patients will receive standard perioperative care. Intraoperative anesthetic requirements and postoperative nausea and vomiting will be assessed and compared with other hormonal status groups.
Eligibility Criteria
The study population consists of female patients aged 18-65 years with American Society of Anesthesiologists (ASA) physical status I-II-III who are scheduled for elective laparoscopic cholecystectomy under general anesthesia. Participants will be classified according to hormonal status (follicular phase, luteal phase, or postmenopausal) based on postoperative serum progesterone levels. All patients will receive standard perioperative care, and no experimental intervention will be applied.
You may qualify if:
- Female patients aged 18 to 65 years
- American Society of Anesthesiologists (ASA) physical status I-II-III
- Scheduled for elective laparoscopic cholecystectomy under general anesthesia
- Willing and able to provide written informed consent
You may not qualify if:
- Age outside the specified range (younger than 18 or older than 65 years)
- Male patients
- American Society of Anesthesiologists (ASA) physical status ≥ IV
- Severe systemic comorbidities (e.g., significant cardiovascular, hepatic, renal, or pulmonary disease)
- Conversion from laparoscopic to open cholecystectomy
- History of alcohol, drug, or substance abuse
- Visual or hearing impairment interfering with study assessments
- Current hormone replacement therapy
- Use of oral contraceptives
- Preoperative nausea or vomiting
- History of severe postoperative nausea and vomiting
- Neurological or psychiatric disorders affecting assessment reliability
- Hemodynamic instability during surgery
- Postoperative admission to intensive care unit
- Acute cholecystitis at the time of surgery
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Etlik City Hospital
Ankara, Ankara, 06170, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
oya çimen, Specialist in Anesthesiology
Ankara Etlik City Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Specialist in Anesthesiology
Study Record Dates
First Submitted
February 28, 2026
First Posted
March 6, 2026
Study Start
March 7, 2026
Primary Completion
May 27, 2026
Study Completion
June 15, 2026
Last Updated
April 30, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Beginning 6 months after publication and available for up to 3 years.
- Access Criteria
- Data will be shared electronically after approval of a formal data request and signing of a data use agreement.
De-identified individual participant data will be available upon reasonable request to the corresponding investigator, following publication of the study results, and subject to institutional and ethical approval.